0000000000172873

AUTHOR

Nina Egger

showing 2 related works from this author

Short-term cost-effectiveness of psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: Results from the SOPHO-NET trial

2015

Abstract Background To investigate the short-term cost-effectiveness of cognitive-behavioral therapy (CBT) and psychodynamic therapy (PDT) compared to waiting list (WL). Methods The analysis was conducted alongside the SOPHO-NET multi-center efficacy trial. Patients were randomly assigned to CBT ( n =209), PDT ( n =207), or WL ( n =79). Resource use was assessed prior and during treatment to determine direct and absenteeism costs. Unadjusted incremental cost-effectiveness ratios (ICERs) were calculated based on remission and response rates. To visualize statistical uncertainty, cost-effectiveness acceptability curves (CEACs) were constructed based on adjusted net-benefit regression. Differe…

MaleMental Health Servicesmedicine.medical_specialtyTime FactorsWaiting ListsCost effectivenessCost-Benefit Analysismedicine.medical_treatmentPsychological interventionGroup psychotherapyIndirect costsWillingness to paymedicineHumansPsychiatryhealth care economics and organizationsCognitive Behavioral TherapyMiddle Aged3. Good healthCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomePhobic DisordersEconomic evaluationAbsenteeismPhysical therapyFemalePsychologyJournal of Affective Disorders
researchProduct

Long-term cost-effectiveness of cognitive behavioral therapy versus psychodynamic therapy in social anxiety disorder.

2015

Background To determine the cost-effectiveness of cognitive behavioral therapy (CBT) versus psychodynamic therapy (PDT) in the treatment of social anxiety disorder after a follow-up of 30 months from a societal perspective. Methods This analysis was conducted alongside the multicenter SOPHO-NET trial; adults with a primary diagnosis of social anxiety disorder received CBT (n = 209) or PDT (n = 207). Data on health care utilization and productivity loss were collected at baseline, after 6 months (posttreatment), and three further follow-ups to calculate direct and indirect costs. Anxiety-free days (AFDs) calculated based on remission and response were used as measure of effect. The increment…

AdultMaleCost effectivenessmedicine.medical_treatmentCost-Benefit AnalysisTime03 medical and health sciencesIndirect costs0302 clinical medicineWillingness to paymedicineHumanshealth care economics and organizationsPsychodynamic psychotherapyCost–benefit analysisCognitive Behavioral TherapySocial anxietyPhobia Social3. Good health030227 psychiatryCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomeCognitive therapyFemalePsychologyPsychotherapy Psychodynamic030217 neurology & neurosurgeryClinical psychologyDepression and anxiety
researchProduct